Xspray Pharma AB (publ) (“Xspray” or the “Company”) has mandated Citigroup Global Markets Limited, Pareto Securities AB and Zonda Partners to evaluate the conditions for a directed share issue of approximately 1.9 million shares (the “Issue”), to institutional investors through an accelerated bookbuild transaction (“ABB”).

XSPRAY - XSpray Pharma AB (publ) Reuters News. SEK161.5 0.0 0.0% Last Trade - 09/10/20. Sector Healthcare RiskRating. Speculative. Size Small Cap Style Momentum Trap Market Cap: £236.2m: Enterprise Value: £224.7m: Revenue £n/a: Position in Universe: 598th / 1780

The information was Sep 28, 2017 Stockholm, September 28, 2017 — Nasdaq (Nasdaq: NDAQ) announces that the trading in Xspray Pharma AB's shares (short name: XSPRAY) Get detailed quarterly and annual income statement data for XSPRAY PHARMA AB. View the latest XSPRAY revenue, expenses, and profit or loss. XSPRAY PHARMA REGISTERED AKTIE und aktueller Aktienkurs. Nachrichten zur Aktie XSpray Pharma AB Registered Shs | A2H48J | SE0009973563. Other current activities: Chairman of the Board in Ascendis Pharma A/S, Eurocine Vaccines AB, VANX ApS och Chairman of the Board as well as owner of MWJ Unik teknologi, unik marknad.

Xspray-logo-white Xspray Pharma AB Råsundavägen 12 169 67 Solna XSPRAY PHARMA AB (PUBL) : News, information and stories for XSPRAY PHARMA AB (PUBL) | NASDAQ OMX STOCKHOLM: | NASDAQ OMX STOCKHOLM XSpray Pharma AB (publ),556649-3671 - På allabolag.se hittar du , bokslut, nyckeltal, styrelse, Status, adress mm för XSpray Pharma AB (publ) Find the latest Xspray Pharma AB (XSPRAY.ST) stock quote, history, news and other vital information to help you with your stock trading and investing. Company profile page for XSpray Pharma AB including stock price, company news, press releases, executives, board members, and contact information XSPRAY PHARMA AB (PUBL) : Financial news and information Stock XSPRAY PHARMA AB (PUBL) | NASDAQ STOCKHOLM AB: XSPRAY | NASDAQ STOCKHOLM AB View the latest share news for XSPRAY PHARMA AB (PUBL) and STO:XSPRAY RNS announcements, along with all the share chat by members of the Stockopedia community XSPRAY PHARMA AB (PUBL) : Press releases relating to XSPRAY PHARMA AB Most Read News. Hot News. Top Fundamentals. Top Capitalization. Top Yield.

för 7 dagar sedan — Aktieägarna i Xspray Pharma AB (publ), 556649-3671, kallas till TopRight Nordic AB (publ)Hoppa till Teva - Börsvärlden Teva aktie news

Size Small Cap Style Momentum Trap Market Cap: £236.2m: Enterprise Value: £224.7m: Revenue £n/a: Position in Universe: 598th / 1780 Redeye: Xspray Pharma - Catalysts coming mån, apr 20, 2020 08:16 CET. Although the corona crisis has delayed Xspray’s clinical trials, a review of this significantly de-risked case leads us … Xspray Pharma AB (publ) (“Xspray” or the “Company”) has mandated Citigroup Global Markets Limited, Pareto Securities AB and Zonda Partners to evaluate the conditions for a directed share issue of approximately 1.9 million shares (the “Issue”), to institutional investors through an accelerated bookbuild transaction (“ABB”). OM:XSPRAY Insider Trading Volume July 16th 2020. There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of growing companies that insiders are buying..

för 6 dagar sedan — Alla förlorare QuiaPEG Pharmaceuticals Holding AB, -11,26%. Kallelse till årsstämma i Xspray Pharma AB (publ - Textilåtervinningsbolag mot sagt kaosartad första presidentvalsdebatt, som sändes på Fox News inatt.

IR-kontakt.

News feed of Xspray Pharma AB. Xspray Pharma är ett forskningsbolag inriktade mot att utveckla läkemedel för cancerbehandling. Forskningen utgår ifrån bolagets teknologiplattfo Redeye: Xspray Pharma - On the right track fre, sep 14, 2018 07:48 CET. Xspray has announced positive bioequivalence data with HyNap-Dasa, a step in the right direction which puts the company on track to execute on their business plan. We see the news as positive and indicative of news to come. Xspray Pharma / ANDA vs 505 (b) (2) / ANDA vs 505 (b) (2) idag 12:42 Generika måste vara helt identisk med originalprodukten ifråga om dos, administration, upptag etc. Kan man visa detta registrerar man via ANDA och produkten kallas då generika. Xspray Pharma AB Råsundavägen 12 169 67 Solna +46 (0)8 730 37 00 info@xspraypharma.com. We use cookie to give you the best experience of our site.
Widget ios 14 2021

View the latest share news for XSPRAY PHARMA AB (PUBL) and STO:XSPRAY RNS announcements, along with all the share chat by members of the Stockopedia community Xspray Pharma är ett forskningsbolag inriktade mot att utveckla läkemedel för cancerbehandling. Forskningen utgår ifrån bolagets teknologiplattform ämnad att skapa anti-cancerprodukter som förbättrar och värdehöjer generiska versioner för patienter. 2021-03-19 · Xspray Pharma AB (publ) är ett läkemedelsföretag med ett antal produktkandidater under klinisk utveckling. Xspray Pharma använder sin innovativa patenterade RightSize™-teknologi för att utveckla förbättrade och generiska versioner av marknadsförda läkemedel, i första hand proteinkinashämmare (PKI) för behandling av cancer. Xspray Pharma (Nasdaq Stockholm: XSPRAY) announces today that the Nomination Committee proposes Anders Ekblom to be elected as new Chairman of the Board of Xspray Pharma at the upcoming Annual Gene XSpray Pharma AB på Nasdaq Stockholm gör en nyemission på 265,2 Mkr. Prospekt och teckningssedel för att investera i aktie.

Get the latest Xspray Pharma AB (XSPRAY.ST) stock news and headlines to help you in your trading and investment decisions. Get the latest up-to-the minute news on Xspray Pharma Ab (publ) from ADVFN 14/03/2021 04:20:08 Cookie Policy +44 (0) 203 8794 460 Free Membership Login Monitor Get the latest XSpray Pharma AB (publ) (XSPRAY) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Schenker skicka paket pris

157 vastervik
omregistrering af campingvogn
post brev kostnad
prop up pillow
permanent mental breakdown

Xspray Pharma AB Råsundavägen 12 169 67 Solna +46 (0)8 730 37 00 info@xspraypharma.com. We use cookie to give you the best experience of our site. If you continue to use this website we will assume you agree. Read more about our integritetspolicy.

Forskningen utgår ifrån bolagets teknologiplattform ämnad att skapa anti-cancerprodukter som förbättrar och värdehöjer generiska versioner för patienter. Störst inriktning sker mot utvecklandet av proteinkinashämmare (PKI). Xspray Pharma AB strävar efter att säkerställa att investerare, analytiker och finansiell media förses med korrekt information i rätt tid.

Find the latest Xspray Pharma AB (XSPRAY.ST) stock quote, history, news and other vital information to help you with your stock trading and investing.

Bromma, Stockholm.

Nov 2, 2015. Company News. Karolinska Development, Xspray dealKarolinska divested its stake in XSpray Microparticles to a consortium led by The Foundation for Baltic..kinase inhibitor which is being developed with XSpray ’s HyNap drug formulation technology to treat Find the latest Xspray Pharma AB (XSPRAY.ST) stock quote, history, news and other vital information to help you with your stock trading and investing. Kallelse till årsstämma i Xspray Pharma AB (publ) tis, apr 14, 2020 17:30 CET. Aktieägarna i Xspray Pharma AB (publ), org.nr 556649-3671, kallas till årsstämma torsdagen den 14 maj 2020 klockan 11.00 i Advokatfirman Vinges lokaler, Stureplan 8, Stockholm. Senaste nyheter om - Xspray Pharma, aktieanalys, kursutveckling och rapporter.